{
    "2021-02-12": [
        [
            {
                "time": "2018-02-06",
                "original_text": "Alnylam's (ALNY) Q4 Loss Wider Than Expected, Revenues Beat",
                "features": {
                    "keywords": [
                        "Alnylam",
                        "Q4 Loss",
                        "Wider Than Expected",
                        "Revenues Beat"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Pharma Stock Roundup: AZN's Q4 Earnings, FDA Approval for LLY & SNY's Drugs",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "AZN Q4 Earnings",
                        "FDA Approval",
                        "LLY Drugs",
                        "SNY Drugs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}